Skip to content

PetIQ is a good deal but has a few fleas

PetIQ (PETQ $14-16) is a small (~$350M sales) growth company doing an $85M IPO with Jefferies and William Blair as lead underwriters. The deal looks solid given that the company is gaining share in the large and growing market of pet medications, health and wellness products and flea and tick treatments. For the whole story see the PETQ IPO slidedeck.

Pet owners know there's a bit of a racket when it comes to getting special foods, medications and wellness products for your dog or cat. In most cases, they . . .

Want the rest of the article?

Please login or join us as a member to view our complete content!